Literature DB >> 31650816

What Stops Doctors Switching from Intravenous to Oral Antibiotics?

D Hogan-Murphy1,2, S Waqas3,2, H Tuite3, U Ni Riain4.   

Abstract

Aims To explore doctors’ perceptions of the motivators and barriers to complying with intravenous to oral switch antibiotic guidelines in a Model 4 Irish hospital. Methods A cross-sectional study was carried out amongst doctors attending hospital-wide educational sessions in November 2018 via a validated paper-based survey post ethical approval. Data were independently analysed using SPSS. Results One hundred and seventy four doctors of all grades and a variety of specialties participated. Respondents felt they were aware of the local intravenous to oral switch criteria but expressed they required prompts to consider switching to oral agents when appropriate, inclusive of alert stickers in the Kardex and medical notes as well as reminders from nursing and pharmacy staff. Other interventions to assist with improved decision-making included further education to junior doctors on the benefits of an intravenous to oral switch, electronic prescribing, and better accessibility to laboratory results. Conclusion Results will assist in implementing quality improvement initiatives to increase the rate of guideline compliance.

Mesh:

Substances:

Year:  2019        PMID: 31650816

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  2 in total

1.  Antibiotic utilization, sensitivity, and cost in the medical intensive care unit of a tertiary care teaching hospital in Nepal.

Authors:  Nirmal Raj Marasine; Shakti Shrestha; Sabina Sankhi; Nabina Paudel; Ashish Gautam; Arjun Poudel
Journal:  SAGE Open Med       Date:  2021-09-03

Review 2.  From basic to advanced computerised intravenous to oral switch for paracetamol and antibiotics: an interrupted time series analysis.

Authors:  Charlotte Quintens; Marie Coenen; Peter Declercq; Minne Casteels; Willy E Peetermans; Isabel Spriet
Journal:  BMJ Open       Date:  2022-04-08       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.